Despite the importance of CD44 and CD133 in various cancers, the clinicopathological and prognostic values of these biomarkers in esophageal cancer remain debated. ...In conclusion, CD44 overexpression was associated with a 5 year overall survival rate and thus this biomarker can be a suitable prognostic tool in esophageal cancer....